Skip to main content
OpenTrials
Completed

NCT Number: NCT00366665

Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems

To compare the efficiency of the Infiniti vision system and the Series 20000 Legacy System phacoemulsification units during routine cataract extraction.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cataract
  • Eligible for cataract extraction with primary implantation of a posterior chamber IOL
  • 2 to 3+ cataract density

Exclusion criteria

  • Preoperative ocular pathology that can affect visual acuity
  • Corneal irregularities such as keratoconus, corneal dystrophy, corneal opacities.
  • Previous intraocular or corneal surgery.
  • Other ocular surgery at the time of the cataract extraction.
  • Surgical Exclusion Criteria:
  • Significant intraoperative intraocular bleeding
  • Detached Descemet's membrane
  • Implantation of the intraocular lens in the anterior chamber or sulcus

Treatment and study plan

Legacy 20000

Device

Infinit system

Device

Primary outcomes

  1. Ultrasound time

  2. Amount of fluid used

  3. Post operative visual acuity.

Sponsors and collaborators

Lead sponsor

Medical University of South Carolina

Other

Registry information

Official study title

Comparison of the Infiniti Vision and the Series 20000 Legacy Systems

Important dates

Study start
2005
Study completion
2005
First posted
Aug 21, 2006
Registry last updated
Aug 21, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.